We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
As part of the supply agreement, BB-NCIPD will provide Stablepharma with their bulk Tetadif vaccine which will then be converted to the StablevaX formulation to produce a thermally stable version.
The UK-EU trade deal will give the UK researchers and businesses access to Horizon Europe funding on equivalent terms as EU counterparts, including eligibility to lead projects.